Tuesday, December 23, 2025 | 08:23 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 18 - Vaccine

US Covid-19 vaccination drive is bottoming out as Omicron subsides

About 76% of the US population has received at least one shot; less than 65% of all Americans are fully vaccinated

US Covid-19 vaccination drive is bottoming out as Omicron subsides
Updated On : 24 Feb 2022 | 12:07 AM IST

Sanofi, GSK to seek regulatory approval for Covid vaccine candidate

Sanofi-GSK's shot relies on a conventional protein-based approach, compared with the newer mRNA technology used in established Covid-19 vaccines from Pfizer-BioNTech and Moderna

Sanofi, GSK to seek regulatory approval for Covid vaccine candidate
Updated On : 23 Feb 2022 | 9:55 PM IST

Moderna, Thermo Fisher partner to manufacture Covid vaccine, other drugs

Thermo Fisher had already partnered with Moderna last year to help scale up production of its Covid vaccine, branded as Spikevax

Moderna, Thermo Fisher partner to manufacture Covid vaccine, other drugs
Updated On : 23 Feb 2022 | 8:04 PM IST

India's Covid-19 vaccination coverage exceeds 175.03 cr, says MoHFW

As per the health ministry, with the administration of 36,28,578 vaccine doses in the last 24 hours, India's Covid-19 vaccination coverage has exceeded 1,75,03,86,834

India's Covid-19 vaccination coverage exceeds 175.03 cr, says MoHFW
Updated On : 19 Feb 2022 | 1:09 PM IST

Over 111.7 mn unutilized Covid vaccine doses available with states, UTs

As part of the nationwide vaccination drive, the Centre has been supporting the states and UTs by providing them Covid-19 vaccines free of cost

Over 111.7 mn unutilized Covid vaccine doses available with states, UTs
Updated On : 19 Feb 2022 | 10:50 AM IST

Foreign Covid vaccine firms can do business here, but on India's terms: Min

Mandaviya also said that the world is astonished by India's vaccination coverage which has reached almost 175 crore, adding that the third Covid-19 wave is on the decline

Foreign Covid vaccine firms can do business here, but on India's terms: Min
Updated On : 19 Feb 2022 | 7:25 AM IST

Moderna eyes Covid booster by August, not clear yet if Omicron-specific

Moderna chief executive Stephane Bancel said in an interview the company aimed to have a booster ready by August 2022, before next autumn when he said more vulnerable people may need it

Moderna eyes Covid booster by August, not clear yet if Omicron-specific
Updated On : 17 Feb 2022 | 7:20 AM IST

Short AstraZeneca shelf life complicates vaccine rollout to world's poorest

Many more vaccines are expected to be rejected as African nations and Covax said that from January they would not accept vaccines with less than two-and-a-half months' shelf life

Short AstraZeneca shelf life complicates vaccine rollout to world's poorest
Updated On : 16 Feb 2022 | 10:27 PM IST

Covid vaccine makers shoot for exports as domestic demand may remain low

ZyCoV-D is already approved by the regulator for use in children aged 12 and more

Covid vaccine makers shoot for exports as domestic demand may remain low
Updated On : 17 Feb 2022 | 6:04 AM IST

New Zealand's Ardern labels anti-vaccine mandate protests 'imported'

Claiming inspiration from truckers' anti-vaccine mandate demonstrations in Canada, the protesters have also blocked several streets around parliament with their trucks, vans and motorcycles

New Zealand's Ardern labels anti-vaccine mandate protests 'imported'
Updated On : 14 Feb 2022 | 9:28 AM IST

Vaccinated warehouse workers can now work unmasked, says Amazon

The company is rolling back a mask requirement it put back into effect during the Omicron surge in December

Vaccinated warehouse workers can now work unmasked, says Amazon
Updated On : 12 Feb 2022 | 4:59 PM IST

Covid: India's first mRNA vaccine under final trials, says govt

Indian Council of Medical Research Director General, Dr Balram Bhargava, said that this is another vaccine which really establishes that India is heading towards becoming a vaccine superpower

Covid: India's first mRNA vaccine under final trials, says govt
Updated On : 10 Feb 2022 | 6:55 PM IST

Omicron's mutations explain why it is less severe among vaccinated

Omicron emerged as a variant of concern only in November 2021, but all the mutations it contains, except one, had been described before that

Omicron's mutations explain why it is less severe among vaccinated
Updated On : 09 Feb 2022 | 8:10 PM IST

ICMR has collected over Rs 171 crore as royalty from Covaxin's sales: Govt

The ICMR has spent around Rs 35 crore in research and development of covid vaccine Covaxin

ICMR has collected over Rs 171 crore as royalty from Covaxin's sales: Govt
Updated On : 08 Feb 2022 | 6:48 PM IST

Vaccine sales pushes Pfizer beyond expectations in final quarter

Pfizer said Tuesday that it expects adjusted earnings in the new year to range from USD 6.35 to USD 6.55 per share on USD 98 billion to USD 102 billion in revenue

Vaccine sales pushes Pfizer beyond expectations in final quarter
Updated On : 08 Feb 2022 | 6:33 PM IST

Covid vaccine: Single-dose Sputnik Light gets DCGI nod for emergency use

Sputnik V is a heterogeneous vaccine which uses two different components in its two doses

Covid vaccine: Single-dose Sputnik Light gets DCGI nod for emergency use
Updated On : 06 Feb 2022 | 11:22 PM IST

Centre places purchase order for 50 mn doses of Corbevax at Rs 145 apiece

The government is yet to decide on which segment of beneficiaries this new vaccine would be administered

Centre places purchase order for 50 mn doses of Corbevax at Rs 145 apiece
Updated On : 05 Feb 2022 | 5:22 PM IST

Triple vaccinated can fight Omicron variant efficiently, study finds

The study, published recently in the journal Nature Medicine, tracked the antibodies of vaccinated and recovered individuals for two years

Triple vaccinated can fight Omicron variant efficiently, study finds
Updated On : 04 Feb 2022 | 6:02 PM IST

Exposure to one nasal droplet may be enough for Covid infection: Study

Among several key clinical insights, researchers found that symptoms start to develop very fast, on average about two days after contact with the virus

Exposure to one nasal droplet may be enough for Covid infection: Study
Updated On : 03 Feb 2022 | 5:00 PM IST

Reports saying 5 mn unused Covishield doses may go waste 'misleading': Govt

It said the Centre had proactively advised all state governments to review the availability of vaccines to ensure that the wastage of doses is reduced to a minimum

Reports saying 5 mn unused Covishield doses may go waste 'misleading': Govt
Updated On : 03 Feb 2022 | 4:17 PM IST